Alyeska Investment Group
PROF

Alyeska Investment Group’s Profound Medical PROF Stock Holding History

Alyeska Investment Group’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-150,000
Closed -$3.45M – 562
2020
Q2 		$3.45M Hold
150,000
– – 0.05% 301
2020
Q1 		$2.03M Hold
150,000
– – 0.04% 257
2019
Q4 		$2.21M Buy
+150,000
New +$1.38M 0.03% 288

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Alyeska Investment Group's PROF Position: Q1 2026 in Review

Alyeska Investment Group sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 678,570 shares — an estimated $5.34M sold.

Alyeska Investment Group first reported a position in PROF in Q1 2020 and held it in 6 quarters. The position peaked at $5.34M in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • Alyeska Investment Group reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 678,570 Profound Medical shares in Q1 2026, an estimated $5.34M.
  • Alyeska Investment Group first reported a position in Profound Medical in Q1 2020 and held it in 6 quarters.
  • Alyeska Investment Group's Profound Medical position peaked at $5.34M in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.